Skip to main content
Erschienen in: Diabetologia 2/2005

01.02.2005 | Article

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

verfasst von: M. Anello, R. Lupi, D. Spampinato, S. Piro, M. Masini, U. Boggi, S. Del Prato, A. M. Rabuazzo, F. Purrello, P. Marchetti

Erschienen in: Diabetologia | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Little information is available on the insulin release properties of pancreatic islets isolated from type 2 diabetic subjects. Since mitochondria represent the site where important metabolites that regulate insulin secretion are generated, we studied insulin release as well as mitochondrial function and morphology directly in pancreatic islets isolated from type 2 diabetic patients.

Methods

Islets were prepared by collagenase digestion and density gradient purification, and insulin secretion in response to glucose and arginine was assessed by the batch incubation method. Adenine nucleotides, mitochondrial membrane potential, the expression of UCP-2, complex I and complex V of the respiratory chain, and nitrotyrosine levels were evaluated and correlated with insulin secretion.

Results

Compared to control islets, diabetic islets showed reduced insulin secretion in response to glucose, and this defect was associated with lower ATP levels, a lower ATP/ADP ratio and impaired hyperpolarization of the mitochondrial membrane. Increased protein expression of UCP-2, complex I and complex V of the respiratory chain, and a higher level of nitrotyrosine were also found in type 2 diabetic islets. Morphology studies showed that control and diabetic beta cells had a similar number of mitochondria; however, mitochondrial density volume was significantly higher in type 2 diabetic beta cells.

Conclusions/interpretation

In pancreatic beta cells from type 2 diabetic subjects, the impaired secretory response to glucose is associated with a marked alteration of mitochondrial function and morphology. In particular, UCP-2 expression is increased (probably due to a condition of fuel overload), which leads to lower ATP, decreased ATP/ADP ratio, with consequent reduction of insulin release.
Literatur
1.
Zurück zum Zitat King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMed
2.
Zurück zum Zitat American Diabetes Association (2000) Type 2 diabetes in children and adolescents (consensus statement). Diabetes Care 23:381–389 American Diabetes Association (2000) Type 2 diabetes in children and adolescents (consensus statement). Diabetes Care 23:381–389
3.
Zurück zum Zitat Adler AI, Boyko EJ, Ahroni JH, Smith DG (1999) Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47). Am Heart J 138:S353–S359 Adler AI, Boyko EJ, Ahroni JH, Smith DG (1999) Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47). Am Heart J 138:S353–S359
4.
Zurück zum Zitat Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412–419CrossRefPubMed Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412–419CrossRefPubMed
5.
Zurück zum Zitat U.K. Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713 U.K. Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713
6.
Zurück zum Zitat Polonsky KS, Sturis J, Bell G (1996) Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783CrossRefPubMed Polonsky KS, Sturis J, Bell G (1996) Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783CrossRefPubMed
7.
Zurück zum Zitat Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
8.
Zurück zum Zitat DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368PubMed DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368PubMed
9.
Zurück zum Zitat Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219CrossRef Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219CrossRef
10.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
11.
Zurück zum Zitat Lohmann D, Jahr H, Verlohren HJ et al (1980) Insulin secretion in maturity-onset-diabetes. Function of isolated islets. Horm Metab Res 12:349–353 Lohmann D, Jahr H, Verlohren HJ et al (1980) Insulin secretion in maturity-onset-diabetes. Function of isolated islets. Horm Metab Res 12:349–353
12.
Zurück zum Zitat Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ (1994) Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 37:177–181CrossRef Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ (1994) Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 37:177–181CrossRef
13.
Zurück zum Zitat Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624–632 Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624–632
14.
Zurück zum Zitat Grodsky GM, Bolaffi JL (1992) Desensitization of the insulin-secreting beta cell. J Cell Biochem 48:3–11 Grodsky GM, Bolaffi JL (1992) Desensitization of the insulin-secreting beta cell. J Cell Biochem 48:3–11
15.
Zurück zum Zitat Leahy JL, Bonner-Weir S, Weir GC (1992) Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442–455 Leahy JL, Bonner-Weir S, Weir GC (1992) Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442–455
16.
Zurück zum Zitat Purrello F, Vetri M, Gatta C, Gullo D, Vigneri R (1989) Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation. Diabetes 38:1417–1422 Purrello F, Vetri M, Gatta C, Gullo D, Vigneri R (1989) Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation. Diabetes 38:1417–1422
17.
Zurück zum Zitat Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 (Suppl 1):S119–S124 Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 (Suppl 1):S119–S124
18.
Zurück zum Zitat Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461–2474PubMed Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461–2474PubMed
19.
Zurück zum Zitat Unger RH, Zhou YT (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50 (Suppl 1):S118–S121 Unger RH, Zhou YT (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50 (Suppl 1):S118–S121
20.
Zurück zum Zitat Wyne KL (2003) Free fatty acids and type 2 diabetes mellitus. Am J Med 115 (Suppl 8A):29S–36SCrossRef Wyne KL (2003) Free fatty acids and type 2 diabetes mellitus. Am J Med 115 (Suppl 8A):29S–36SCrossRef
21.
Zurück zum Zitat Poitout V, Robertson RP (2002) Secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342PubMed Poitout V, Robertson RP (2002) Secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342PubMed
22.
Zurück zum Zitat Maechler P (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 59:1803–1818 Maechler P (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 59:1803–1818
23.
Zurück zum Zitat Wollheim CB, Maechler P (2002) Beta-cell mitochondria and insulin secretion: messenger role of nucleotides and metabolites. Diabetes 51 (Suppl 1):S37–S42 Wollheim CB, Maechler P (2002) Beta-cell mitochondria and insulin secretion: messenger role of nucleotides and metabolites. Diabetes 51 (Suppl 1):S37–S42
24.
Zurück zum Zitat Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic beta-cells. Nature 13:807–812CrossRef Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic beta-cells. Nature 13:807–812CrossRef
25.
Zurück zum Zitat Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F, Henquin JC (1998) The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J Biol Chem 273:33905–33908CrossRef Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F, Henquin JC (1998) The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J Biol Chem 273:33905–33908CrossRef
26.
Zurück zum Zitat Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed
27.
Zurück zum Zitat Chan CB, Saleh MC, Koshkin V, Wheeler MB (2004) Uncoupling protein 2 and islet function. Diabetes 53 (Suppl 1):S136–S142 Chan CB, Saleh MC, Koshkin V, Wheeler MB (2004) Uncoupling protein 2 and islet function. Diabetes 53 (Suppl 1):S136–S142
28.
Zurück zum Zitat Rousset S, Alves-Guerra MC, Mozo J et al (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl 1):S130–S135 Rousset S, Alves-Guerra MC, Mozo J et al (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl 1):S130–S135
29.
Zurück zum Zitat Saleh MC, Wheeler MB, Chan CB (2002) Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45:174–187CrossRef Saleh MC, Wheeler MB, Chan CB (2002) Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45:174–187CrossRef
30.
Zurück zum Zitat Zhang CY, Baffy G, Perret P et al (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 15:745–755CrossRef Zhang CY, Baffy G, Perret P et al (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 15:745–755CrossRef
31.
Zurück zum Zitat Chan CB, De Leo D, Joseph JW et al (2001) Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50:1302–1310 Chan CB, De Leo D, Joseph JW et al (2001) Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50:1302–1310
32.
Zurück zum Zitat Marchetti P, Dotta F, Ling Z et al (2000) Function of pancreatic islets isolated from Type 1 diabetic patient. Diabetes Care 23:701–703 Marchetti P, Dotta F, Ling Z et al (2000) Function of pancreatic islets isolated from Type 1 diabetic patient. Diabetes Care 23:701–703
33.
Zurück zum Zitat Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets. Evidence that β-cell death is caspase-mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442 Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets. Evidence that β-cell death is caspase-mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442
34.
Zurück zum Zitat Marchetti P, Lupi R, Federici M et al (2002) Insulin secretory function is impaired in isolated human islets carrying the Gly(972)→Arg IRS-1 polymorphism. Diabetes 51:1419–1424 Marchetti P, Lupi R, Federici M et al (2002) Insulin secretory function is impaired in isolated human islets carrying the Gly(972)→Arg IRS-1 polymorphism. Diabetes 51:1419–1424
35.
Zurück zum Zitat Gatto C, Callegari M, Folin M et al (2003) Effects of cryopreservation and coculture with pancreatic ductal epithelial cells on insulin secretion from human pancreatic islets. Int J Mol Med 12:851–854 Gatto C, Callegari M, Folin M et al (2003) Effects of cryopreservation and coculture with pancreatic ductal epithelial cells on insulin secretion from human pancreatic islets. Int J Mol Med 12:851–854
36.
Zurück zum Zitat Anello M, Ucciardello V, Piro S et al (2001) Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP/ADP ratio. Am J Physiol Endocrinol Metab 281:E1082–E1087 Anello M, Ucciardello V, Piro S et al (2001) Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP/ADP ratio. Am J Physiol Endocrinol Metab 281:E1082–E1087
37.
Zurück zum Zitat Hampp R (1986) Luminometric method. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlagsgesellschaft, Weinheim, Germany, pp 370–379 Hampp R (1986) Luminometric method. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlagsgesellschaft, Weinheim, Germany, pp 370–379
38.
Zurück zum Zitat Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804 Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804
39.
Zurück zum Zitat Weibel ER (1969) Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26:235–302 Weibel ER (1969) Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26:235–302
40.
Zurück zum Zitat Duchen MR, Smith PA, and Ashcroft FM (1993) Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic β-cells. Biochem J 294:35–42 Duchen MR, Smith PA, and Ashcroft FM (1993) Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic β-cells. Biochem J 294:35–42
41.
Zurück zum Zitat Krauss S, Zhang CY, Scorrano L et al (2003) Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112:1831–1842CrossRefPubMed Krauss S, Zhang CY, Scorrano L et al (2003) Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112:1831–1842CrossRefPubMed
42.
Zurück zum Zitat Brownlee M (2003) A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 112:1788–1790CrossRef Brownlee M (2003) A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 112:1788–1790CrossRef
43.
Zurück zum Zitat Polonsky KS, Semenkovich CF (2001) The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes. Cell 105:705–707CrossRef Polonsky KS, Semenkovich CF (2001) The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes. Cell 105:705–707CrossRef
44.
Zurück zum Zitat Joseph JW, Koshkin V, Zhang CY (2002) Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51:3211–3219 Joseph JW, Koshkin V, Zhang CY (2002) Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51:3211–3219
45.
Zurück zum Zitat Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB (1999) Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48:1482–1486PubMed Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB (1999) Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48:1482–1486PubMed
46.
Zurück zum Zitat Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM (2002) Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51:2749–2756 Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM (2002) Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51:2749–2756
47.
Zurück zum Zitat Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921CrossRef Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921CrossRef
48.
Zurück zum Zitat Brown JE, Thomas S, Digby JE, Dunmore SJ (2002) Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett 27:189–192CrossRef Brown JE, Thomas S, Digby JE, Dunmore SJ (2002) Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett 27:189–192CrossRef
49.
Zurück zum Zitat Medvedev AV, Robidoux J, Bai X et al (2002) Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem 277:42639–42644CrossRef Medvedev AV, Robidoux J, Bai X et al (2002) Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem 277:42639–42644CrossRef
50.
Zurück zum Zitat Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F (2001) Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50:803–809 Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F (2001) Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50:803–809
51.
Zurück zum Zitat Wang MY, Shimabukuro M, Lee Y et al (1999) Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes 48:1020–1025 Wang MY, Shimabukuro M, Lee Y et al (1999) Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes 48:1020–1025
52.
Zurück zum Zitat Wakabayashi T (2002) Megamitochondria formation—physiology and pathology. J Cell Mol Med 6:497–538 Wakabayashi T (2002) Megamitochondria formation—physiology and pathology. J Cell Mol Med 6:497–538
53.
Zurück zum Zitat Wakabayashi T, Karbowski M (2001) Structural changes of mitochondria related to apoptosis. Biol Signals Recept 10:26–56CrossRef Wakabayashi T, Karbowski M (2001) Structural changes of mitochondria related to apoptosis. Biol Signals Recept 10:26–56CrossRef
54.
Zurück zum Zitat Karbowski M, Kurono C, Wozniak M et al (1999) Free radical-induced megamitochondria formation and apoptosis. Free Radic Biol Med 26:396–409CrossRef Karbowski M, Kurono C, Wozniak M et al (1999) Free radical-induced megamitochondria formation and apoptosis. Free Radic Biol Med 26:396–409CrossRef
55.
Zurück zum Zitat Vincent AM, Brownlee M, Russell JW (2002) Oxidative stress and programmed cell death in diabetic neuropathy. Ann NY Acad Sci 959:368–383 Vincent AM, Brownlee M, Russell JW (2002) Oxidative stress and programmed cell death in diabetic neuropathy. Ann NY Acad Sci 959:368–383
56.
Zurück zum Zitat Pai GM, Slavin BG, Tung P (1993) Morphologic basis for loss of regulated insulin secretion by isolated rat pancreatic islets. Anat Rec 237:498–505 Pai GM, Slavin BG, Tung P (1993) Morphologic basis for loss of regulated insulin secretion by isolated rat pancreatic islets. Anat Rec 237:498–505
57.
Zurück zum Zitat Marselli L, Dotta F, Piro S et al (2001) Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86:4974–4978CrossRef Marselli L, Dotta F, Piro S et al (2001) Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86:4974–4978CrossRef
58.
Zurück zum Zitat Trincavelli ML, Marselli L, Falleni A et al (2002) Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets. J Cell Biochem 84:636–644 Trincavelli ML, Marselli L, Falleni A et al (2002) Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets. J Cell Biochem 84:636–644
Metadaten
Titel
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients
verfasst von
M. Anello
R. Lupi
D. Spampinato
S. Piro
M. Masini
U. Boggi
S. Del Prato
A. M. Rabuazzo
F. Purrello
P. Marchetti
Publikationsdatum
01.02.2005
Erschienen in
Diabetologia / Ausgabe 2/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1627-9

Weitere Artikel der Ausgabe 2/2005

Diabetologia 2/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.